08:29 AM EDT, 08/21/2024 (MT Newswires) -- Health-care marketplace Sesame will offer Novo Nordisk's ( NVO ) weight-loss drug Wegovy to qualified customers for $249 per month, CNBC reported Wednesday, citing a company statement.

The company also said it is adding semaglutide, the active ingredient in Wegovy, to its branded weight loss and diabetes drug offerings.

Michael Botta, president and co-founder of Sesame, told CNBC he thinks its price is "probably the most affordable price point the consumer can find" for the drug.

Sesame did not immediately reply to MT Newswires' request for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 135.51, Change: -0.29, Percent Change: -0.22